ACER THERAPEUTICS INC - COM (ACER)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
2,612,110
Share change
+148,144
Total reported value
$8,328,791
Price per share
$3.19
Number of holders
35
Value change
+$402,476
Number of buys
22
Number of sells
17

Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q3 2019

As of 30 Sep 2019, ACER THERAPEUTICS INC - COM (ACER) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,612,110 shares. The largest 10 holders included Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, J. Goldman & Co LP, STATE STREET CORP, Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, BARCLAYS PLC, NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.